BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6493218)

  • 1. Tuftsin (Thr-Lys-Pro-Arg), a natural modulator of macrophage activity: further studies.
    Bump NJ; Najjar VA
    Mol Cell Biochem; 1984 Sep; 63(2):137-42. PubMed ID: 6493218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of tuftsin and rigin derivatives containing monosaccharides or monosaccharide derivatives.
    Rocchi R; Biondi L; Cavaggion F; Filira F; Gobbo M; Dagan S; Fridkin M
    Int J Pept Protein Res; 1987 Feb; 29(2):262-75. PubMed ID: 3570666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuftsin, a natural activator of phagocytic functions including tumoricidal activity.
    Najjar VA; Konopinska D; Chaudhuri MK; Schmidt DE; Linehan L
    Mol Cell Biochem; 1981 Dec; 41():3-12. PubMed ID: 6895774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic peptides from C-reactive protein containing tuftsin-related sequences.
    Buchta R; Fridkin M; Pontet M; Romeo D
    Peptides; 1986; 7(6):961-8. PubMed ID: 3031632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-mediated endocytosis of tuftsin by macrophage cells.
    Gottlieb P; Hazum E; Tzehoval E; Feldman M; Segal S; Fridkin M
    Biochem Biophys Res Commun; 1984 Feb; 119(1):203-11. PubMed ID: 6322775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo immunopharmacological properties of tuftsin (Thr-Lys-Pro-Arg) and some analogues.
    Florentin I; Chung V; Martinez J; Maral J; Le Garrec Y; Mathé G
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):73-80. PubMed ID: 2423822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical aspects of tuftsin deficiency syndrome.
    Najjar VA
    Med Biol; 1981 Jun; 59(3):134-8. PubMed ID: 6895538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tuftsin].
    Mücke D
    Allerg Immunol (Leipz); 1984; 30(3):127-38. PubMed ID: 6209973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuftsin: its chemistry, biology, and clinical potential.
    Fridkin M; Najjar VA
    Crit Rev Biochem Mol Biol; 1989; 24(1):1-40. PubMed ID: 2667894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuftsin-macrophage interaction: specific binding and augmentation of phagocytosis.
    Bar-Shavit Z; Stabinsky Y; Fridkin M; Goldman R
    J Cell Physiol; 1979 Jul; 100(1):55-62. PubMed ID: 381320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of phagocytic activity of murine Kupffer cells by tuftsin.
    Kubo S; Rodriguez T; Roh MS; Oyedeji C; Romsdahl MM; Nishioka K
    Hepatology; 1994 Apr; 19(4):1044-9. PubMed ID: 8138244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADP-ribosylation of tuftsin suppresses its receptor-binding capacity and phagocytosis-stimulating activity to murine peritoneal macrophages.
    Terashima M; Hara N; Badruzzaman M; Shimoyama M; Tsuchiya M
    FEBS Lett; 1997 Jul; 412(1):227-32. PubMed ID: 9257725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuftsin, a natural activator of phagocyte cells: an overview.
    Najjar VA
    Ann N Y Acad Sci; 1983; 419():1-11. PubMed ID: 6370072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuftsin stimulates the release of oxygen radicals and thromboxane from macrophages.
    Hartung HP; Toyka KV
    Immunol Lett; 1983 Jan; 6(1):1-6. PubMed ID: 6687720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The similarity between tuftsin (Thr-Lys-Pro-Arg) receptors and tuftsin antibody: a case of induced molecular mimicry.
    Chaudhuri MK; Konopińska D; Bump NJ; Najjar VA
    Ann N Y Acad Sci; 1983; 419():135-42. PubMed ID: 6324634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the peptide chain length of new elongated tuftsin analogs on phagocytosis process.
    Konopińska D; Kazanowska B; Bogusławska-Jaworska J
    Int J Pept Protein Res; 1984 Sep; 24(3):267-73. PubMed ID: 6594319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of human lepromatous monocyte-macrophage functions in vitro by tuftsin.
    Iyer RR; Prasad HK; Bhutani LK; Rao DN
    Int J Immunopharmacol; 1990; 12(8):847-58. PubMed ID: 2292463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuftsin analogues: synthesis, structure-function relationships, and implications for specificity of tuftsin's bioactivity.
    Dagan S; Gottlieb P; Tzehoval E; Feldman M; Fridkin M; Yasumura K; Okamoto K; Yajima H
    J Med Chem; 1986 Oct; 29(10):1961-8. PubMed ID: 3761314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuftsin signals through its receptor neuropilin-1 via the transforming growth factor beta pathway.
    Nissen JC; Selwood DL; Tsirka SE
    J Neurochem; 2013 Nov; 127(3):394-402. PubMed ID: 24033337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuftsin, Thr-Lys-Pro-Arg. Anatomy of an immunologically active peptide.
    Fridkin M; Gottlieb P
    Mol Cell Biochem; 1981 Dec; 41():73-97. PubMed ID: 7035869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.